Entyvio (vedolizumab) 300 mg, 1 vial, Takeda Entyvio (vedolizumab) is used for approved inflammatory bowel disease indications including ulcerative colitis. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
Delivery methods
- We can ship by mail to any European country with a delivery time of 8-10 days. Only medications that do not require refrigeration possible shipping. Shipping costs are 40-50 euro, depending on the destination country.
Delivery time
- Originator medicines: 8-10 days
- Generic medicines: 8-10 days
Payment methods
- Bank transfer to the settlement account after receiving the order
Indications
- Treatment of the active course of moderate to severe non-specific ulcerative colitis in adult patients in the absence of an adequate response, loss of response or intolerance to standard therapy or tumor necrosis factor alpha (TNF-α) antagonists.
- Treatment of active moderate to severe Crohn's disease in adult patients with inadequate response, loss of response or intolerance to standard therapy or tumor necrosis factor alpha (TNF-α) antagonists.
- Trade name:Entyvio
- Chemical name:Vedolizumab
- Dosage:300 mg
- Quantity:1
- Dosage form:Vial
No reviews yet
